Traws Pharma (TRAW) Director Werner Receives Option Award

What Happened

• Werner Cautreels, a director of Traws Pharma (TRAW), received an award of 14,150 derivative securities (stock options) on 2026-07-09. The filing shows an acquisition price of $0.00 and reports the transaction as an award/grant (code A), meaning options were granted rather than shares bought or sold. The reported dollar value for the grant in the filing is $0.

Key Details

• Transaction date: 2026-07-09; Filing date (SEC Form 4): 2026-07-15 (appears filed late relative to the typical 2-business-day requirement).
• Security: Stock options (derivative); Amount: 14,150 options; Reported price: $0.00.
• Vesting: Per footnote, the options were awarded under the Issuer’s 2021 Incentive Compensation Plan and will vest 100% on the first anniversary of the grant date.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• No 10b5-1 plan, tax withholding, or exercise/sale noted in the provided data.

Context

• This was an options grant (compensation award) from the company’s independent compensation committee, not an open-market purchase or sale. Grants are routine for directors as part of pay packages and do not indicate an immediate cash transaction or exercise. The options vest in one year; they are not exercised or sold at the time of the grant.